VYNE Therapeutics
VYNE
VYNE
72 hedge funds and large institutions have $64M invested in VYNE Therapeutics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 34
58% less capital invested
Capital invested by funds: $154M → $64M (-$90M)
Holders
72
Holding in Top 10
1
Calls
$366K
Puts
$40K
Top Buyers
| 1 | +$2.58M | |
| 2 | +$2.29M | |
| 3 | +$1.09M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$743K |
| 5 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
+$702K |
Top Sellers
| 1 | -$9.02M | |
| 2 | -$3.51M | |
| 3 | -$2.67M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$1.61M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.49M |